Annual rank65
Sweden · Healthcare
Medicover
Provides healthcare services based on integrated-care and fee-for-service models, alongside laboratory testing across major clinical-pathology areas.
FY2022–FY2025
FY2022–FY2025
FY2022–FY2025
current context only
Company profile
Care networks, laboratories and patient access
Medicover combines patient care with laboratory diagnostics across Europe and India. Healthcare Services spans employer-funded subscriptions, clinics, hospitals, dentistry, fertility care, mental-health centres and wellbeing facilities. Diagnostic Services links laboratories and local collection points in a hub-and-spoke network, offering routine testing alongside genetics and histopathology. The result is a group that both delivers care and supplies information used along the clinical pathway.
Healthcare services
From an employee benefit to a broad care network
Medicover's original model finances and delivers prepaid healthcare for employers and individuals. It now sits beside fee-for-service and publicly funded care across medical clinics, hospitals, dental practices, fertility clinics, mental-health centres, pharmacies, optical outlets and gyms.
- Healthcare Services Prevention, specialist care, hospitals, dentistry and wellbeing
- Explore the care network Clinics, hospitals, fertility, dental, mental-health and fitness settings
- How care is funded Subscriptions, insurance, fee-for-service and public contracts
- Quality approach How the two divisions organise care and laboratory quality
Laboratory diagnostics
When tissue slides become shareable data
Diagnostic Services offers over 12,000 parameters. Its hub-and-spoke system moves samples to core and specialist laboratories; in histopathology, glass slides can instead be scanned and shared. Medicover's digital platform connects more than 100 pathologists with core laboratories in Serbia, Poland and Romania, allowing difficult tissue cases and second opinions to travel electronically.
- Diagnostic Services The laboratory division and its role in clinical decisions
- Inside the hub-and-spoke network Central, regional, hospital and specialist laboratories
- Explore the test menu From clinical chemistry and microbiology to genetics and pathology
- Medicover Genetics Gene panels, reproductive health, oncology and whole-exome testing
- Digital histopathology network Core laboratories, scanners and more than 100 connected pathologists
- ▶ VideoWatch: digital pathology at Medicover The head of histopathology explains how glass slides become remote diagnostic images
Geography and brands
Local names connect a multi-market diagnostic footprint
The diagnostic network operates in fifteen European markets, with brands adapted to local systems: Synevo in Romania and Ukraine, IMD and specialist clinic networks in Germany, and beo-lab in Serbia. Healthcare Services adds major operations in Poland, Romania and India, where the group runs a growing hospital network.
- Diagnostic markets and brands Synevo, IMD, beo-lab and other country networks
- Company directory Verified operating companies, hospitals and laboratory businesses by country
- People and clinical partners The workforce and external networks supporting care delivery
- Medicover in brief The two divisions and their international footprint
Operating model and origin
Digital access builds on a Warsaw subscription idea
Medicover uses online ordering, patient applications, remote consultations and laboratory automation to widen access and raise utilisation. Its strategy combines service expansion, laboratory optimisation, technology and selective acquisitions. The origin is memorable: the first Warsaw clinic opened in 1995, and an early logo was sketched on a napkin during a flight to Poland.
- Digital access to care Online ordering, applications, remote consultations and automation
- Mission and strategy Service expansion, operational excellence, technology and acquisitions
- The first Warsaw clinic A prepaid-care concept, a helicopter decision and the napkin logo
- How the model developed Care pathways, remote consultations and later milestones
Official profile sources: 1993-1995 | Medicover · Medicover in brief | Medicover
Current 2026 update
What has changed in 2026?
Q2 2026 · 22 July 2026
Q2 2026latest official update
4company-specific highlights
+0.1%2026 stock return · context only
Revenue
Q2 revenue increased 7.3% to EUR 640.4 million; organic growth was 11.8%.
Operating profit
Operating profit rose 22.6% to EUR 51.2 million and the operating margin improved to 8.0% from 7.0%.
Profit
Net profit increased 32.1% to EUR 23.9 million, with margin rising to 3.7% from 3.0%.
Cash flow and net loans
H1 free recurring cash flow fell 12.9% to EUR 54.3 million; loans payable net of cash and liquid short-term investments rose EUR 11.5 million from year-end to EUR 809.2 million.
Official 2026 sources: Interim report April-June 2026 · 22 July 2026
Annual record
Ranking history
Future editions add rows; they do not rewrite the 2026 record.
| Edition | Measurement period | Rank | Revenue growth | Net-income growth | Stock return |
|---|---|---|---|---|---|
| 2026 | FY2022–FY2025 | 65 | +58% | +541% | +62% |